In light of these findings, a thorough assessment of CD4+ T cells and B cell population involved in maintaining long-term immunity to cholera after “LPS + LPS‐MSC‐CM” vaccine under controlled clinical settings seems warranted. The gene discussed is CD4; the disease is vibrio infectious disease.